Accession Number: | 0001104659-23-009959 |
Date: | 2023-01-31 |
Issuer: | SUPERNUS PHARMACEUTICALS, INC. (SUPN) |
Original Submission Date: |
KHATTAR JACK A.
C/O SUPERNUS PHARMACEUTICALS, INC.
9715 KEY WEST AVENUE
ROCKVILLE, MD 20850
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2023-01-31 | M | 1,620 | a | $9.56 | 795,937 | direct | ||
COMMON STOCK | 2023-01-31 | S | 976 | d | $42.01 | 794,961 | direct | ||
COMMON STOCK | 2023-01-31 | 0 | $0.00 | 1,047,700 | indirect |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EMPLOYEE STOCK OPTION (RIGHT TO BUY) | 9.56 | 2023-01-31 | deemed execution date | M | 1,620 (d) | 2024-01-23 | common stock 1,620 | $9.56 | 48,380 | direct |
ID | footnote |
---|---|
f1 | transaction made pursuant to a 10b5-1 trading plan adopted september 15, 2022. |
f2 | the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $42.00 to $42.07, inclusive. the reporting person undertakes to provide to supernus pharmaceuticals, inc. ("supernus"), any security holder of supernus, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this form 4. |
f3 | the options vested in four equal annual installments beginning on january 23, 2015. |